1,165 Shares in CME Group Inc. $CME Purchased by Berkshire Asset Management LLC PA

Key Points

• Berkshire Asset Management LLC has made a new investment of approximately $329,000 in CME Group Inc., acquiring 1,165 shares during the first quarter of the year.
• Other institutional investors have also significantly increased their holdings in CME Group, with GQG Partners raising their stake by 7,676.3% in the first quarter.
• CME Group has recently declared a quarterly dividend of $1.25 per share, representing an annual yield of 1.8% and a payout ratio of 48.40%.

Berkshire Asset Management LLC PA acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,165 shares of the financial services provider's stock, valued at approximately $329,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in CME. BI Asset Management Fondsmaeglerselskab A S raised its position in CME Group by 427.1% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 74,879 shares of the financial services provider's stock valued at $19,865,000 after buying an additional 60,672 shares during the period. Wellington Management Group LLP boosted its position in CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock worth $704,068,000 after acquiring an additional 2,089,935 shares during the period. Korea Investment CORP grew its stake in CME Group by 2.9% during the 1st quarter. Korea Investment CORP now owns 222,073 shares of the financial services provider's stock valued at $58,914,000 after acquiring an additional 6,186 shares in the last quarter. Aptus Capital Advisors LLC increased its holdings in shares of CME Group by 6.9% in the 1st quarter. Aptus Capital Advisors LLC now owns 5,575 shares of the financial services provider's stock valued at $1,479,000 after purchasing an additional 358 shares during the period. Finally, Aviso Financial Inc. increased its holdings in shares of CME Group by 6.2% in the 1st quarter. Aviso Financial Inc. now owns 24,399 shares of the financial services provider's stock valued at $6,473,000 after purchasing an additional 1,433 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Performance

Shares of NASDAQ:CME traded down $3.80 during trading on Friday, reaching $269.52. The stock had a trading volume of 1,591,589 shares, compared to its average volume of 1,923,555. The firm has a market capitalization of $97.13 billion, a price-to-earnings ratio of 26.09, a P/E/G ratio of 4.88 and a beta of 0.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $206.44 and a 52 week high of $290.79. The stock has a fifty day simple moving average of $275.82 and a two-hundred day simple moving average of $268.50.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the firm posted $2.56 earnings per share. CME Group's revenue was up 10.4% compared to the same quarter last year. As a group, analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio is 48.40%.

Analyst Ratings Changes

A number of research firms have issued reports on CME. UBS Group reiterated a "neutral" rating and issued a $305.00 target price on shares of CME Group in a research report on Thursday, July 24th. Oppenheimer upped their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Piper Sandler increased their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Barclays set a $298.00 price objective on CME Group and gave the company an "equal weight" rating in a research report on Thursday, July 24th. Finally, Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Four equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, CME Group has a consensus rating of "Hold" and an average price target of $261.93.

Insider Buying and Selling at CME Group

In other news, Director William R. Shepard bought 256 shares of CME Group stock in a transaction dated Wednesday, June 25th. The shares were bought at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the purchase, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Charles P. Carey sold 500 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the sale, the director directly owned 4,900 shares of the company's stock, valued at $1,300,215. This represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.